Sun Pharma Advanced Research’s net loss widens to Rs 83 crore in Q2

10 Nov 2020 Evaluate

Sun Pharma Advanced Research (SPARC) has reported results for second quarter ended September 30, 2020.

The company has reported net loss of Rs 83.49 crore for the quarter under review as against net loss of Rs 63.16 crore for the same quarter in the previous year. However, total income of the company increased 5.19% at Rs 20.46 crore for Q2FY21 as compared Rs 19.45 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

132.60 -1.15 (-0.86%)
30-Dec-2025 13:39 View Price Chart
Peers
Company Name CMP
Syngene Internation. 639.15
Indegene 520.40
CMS Info Systems 342.70
Sagility 52.22
Smartworks Coworking 468.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×